Observational analysis shows palladium-catalyzed synthesis of C4-carbamoylated indoles and C10-aminophenanthridinones, indicating a breakthrough in heterocyclic compound development.
Palladium-catalyzed switchable β-carbon elimination to extrude norbornene for selective synthesis of different heterocyclic skeletons is a long-standing challenge. Herein, we describe the switchable chemoselective synthesis of biologically active C4-carbamoylated indoles and C10-aminophenanthridinones by controlling β-carbon elimination, using chlorocarbamates as C-H carbamoylation reagents. Among them, C4-carbamoylated indoles are used for the synthesis of M2 receptor antagonists and p38α inhibitors. Mechanistic studies show that when β-carbon elimination is inhibited, the catalytic cycle goes through C-N bond coupling and retro-Diels-Alder reaction to generate C4-carbamoylated indoles. Alternatively, when β-carbon elimination to extrude norbornene occurs, an intramolecular C-H arylation cyclization reaction generates C10-aminophenanthridinones.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: